These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22354768)

  • 1. Automated image analysis of nuclear shape: what can we learn from a prematurely aged cell?
    Driscoll MK; Albanese JL; Xiong ZM; Mailman M; Losert W; Cao K
    Aging (Albany NY); 2012 Feb; 4(2):119-32. PubMed ID: 22354768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells.
    Cao K; Graziotto JJ; Blair CD; Mazzulli JR; Erdos MR; Krainc D; Collins FS
    Sci Transl Med; 2011 Jun; 3(89):89ra58. PubMed ID: 21715679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
    Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
    J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus rescues multiple cellular defects in laminopathy-patient fibroblasts.
    DuBose AJ; Lichtenstein ST; Petrash NM; Erdos MR; Gordon LB; Collins FS
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4206-4211. PubMed ID: 29581305
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapamycin activates autophagy in Hutchinson-Gilford progeria syndrome: implications for normal aging and age-dependent neurodegenerative disorders.
    Graziotto JJ; Cao K; Collins FS; Krainc D
    Autophagy; 2012 Jan; 8(1):147-51. PubMed ID: 22170152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype.
    Gabriel D; Gordon LB; Djabali K
    PLoS One; 2016; 11(12):e0168988. PubMed ID: 28033363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
    Yang SH; Bergo MO; Toth JI; Qiao X; Hu Y; Sandoval S; Meta M; Bendale P; Gelb MH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10291-6. PubMed ID: 16014412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
    Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
    Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
    Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
    Bifulco M; D'Alessandro A; Paladino S; Malfitano AM; Notarnicola M; Caruso MG; Laezza C
    FEBS J; 2013 Dec; 280(23):6223-32. PubMed ID: 24112551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome.
    Wang Y; Ostlund C; Worman HJ
    Nucleus; 2010; 1(5):432-9. PubMed ID: 21326826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity.
    García-Aguirre I; Alamillo-Iniesta A; Rodríguez-Pérez R; Vélez-Aguilera G; Amaro-Encarnación E; Jiménez-Gutiérrez E; Vásquez-Limeta A; Samuel Laredo-Cisneros M; Morales-Lázaro SL; Tiburcio-Félix R; Ortega A; Magaña JJ; Winder SJ; Cisneros B
    Aging Cell; 2019 Oct; 18(5):e13002. PubMed ID: 31305018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
    Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
    Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
    Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts.
    Bikkul MU; Clements CS; Godwin LS; Goldberg MW; Kill IR; Bridger JM
    Biogerontology; 2018 Dec; 19(6):579-602. PubMed ID: 29907918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased mechanosensitivity and nuclear stiffness in Hutchinson-Gilford progeria cells: effects of farnesyltransferase inhibitors.
    Verstraeten VL; Ji JY; Cummings KS; Lee RT; Lammerding J
    Aging Cell; 2008 Jun; 7(3):383-93. PubMed ID: 18331619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisomal abnormalities and catalase deficiency in Hutchinson-Gilford Progeria Syndrome.
    Mao X; Bharti P; Thaivalappil A; Cao K
    Aging (Albany NY); 2020 Mar; 12(6):5195-5208. PubMed ID: 32186522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.
    Liu GH; Barkho BZ; Ruiz S; Diep D; Qu J; Yang SL; Panopoulos AD; Suzuki K; Kurian L; Walsh C; Thompson J; Boue S; Fung HL; Sancho-Martinez I; Zhang K; Yates J; Izpisua Belmonte JC
    Nature; 2011 Apr; 472(7342):221-5. PubMed ID: 21346760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hutchinson-Gilford progeria syndrome through the lens of transcription.
    Prokocimer M; Barkan R; Gruenbaum Y
    Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria.
    Cenni V; Capanni C; Columbaro M; Ortolani M; D'Apice MR; Novelli G; Fini M; Marmiroli S; Scarano E; Maraldi NM; Squarzoni S; Prencipe S; Lattanzi G
    Eur J Histochem; 2011 Oct; 55(4):e36. PubMed ID: 22297442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.